Mark Fraser
Impact in
- Microbiology top 5%
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
-
- Antifungal resistance and susceptibility 16
- Epidemiology 12
- Fungal Infections and Studies 10
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Nail Diseases and Treatments 2
- Co-authors
- Andrew M. Borman (22 shared papers)Elizabeth M. Johnson (19 shared papers)M. Dean Palmer (8 shared papers)Colin Campbell (1 shared paper)Adrien Székely (6 shared papers)Zoe Patterson (7 shared papers)Zoe Ann Brown (1 shared paper)Christopher J. Linton (5 shared papers)
- Journals
- Medical Mycology (8 papers)Journal of Fungi (3 papers)Journal of Clinical Microbiology (3 papers)Mycopathologia (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United KingdomNetherlandsSaudi Arabia
In The Last Decade
Mark Fraser
24 papers receiving 765 citations
Peers
Comparison fields: 5 of 70
- Microbiology 20
- Infectious Diseases 419
- Cell Biology 240
- Epidemiology 439
- Clinical Biochemistry 64
Countries citing papers authored by Mark Fraser
This map shows the geographic impact of Mark Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Fraser more than expected).
Fields of papers citing papers by Mark Fraser
This network shows the impact of papers produced by Mark Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Fraser. The network helps show where Mark Fraser may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Fraser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 148 | |
| 2 | 2015 | 70 | |
| 3 | 2020 | 69 | |
| 4 | 2020 | 65 | |
| 5 | 2019 | 55 | |
| 6 | 2017 | 55 | |
| 7 | 2017 | 41 | |
| 8 | 2020 | 35 | |
| 9 | 2019 | 34 | |
| 10 | 2021 | 31 | |
| 11 | 2023 | 29 | |
| 12 | 2010 | 28 | |
| 13 | 2017 | 25 | |
| 14 | 2019 | 24 | |
| 15 | 2018 | 18 | |
| 16 | 2022 | 12 | |
| 17 | 2015 | 12 | |
| 18 | 2015 | 9 | |
| 19 | 2012 | 9 | |
| 20 | 2022 | 7 |
About Mark Fraser
Mark Fraser is a scholar working on Infectious Diseases, Epidemiology, Cell Biology, Plant Science and Pharmacology, having authored 25 papers that have together received 793 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (16 papers), Fungal Infections and Studies (10 papers), Plant Pathogens and Fungal Diseases (9 papers), Mycorrhizal Fungi and Plant Interactions (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Enterobacteriaceae and Cronobacter Research (2 papers), Nail Diseases and Treatments (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Microbiology (20 citations), Infectious Diseases (419 citations), Cell Biology (240 citations), Epidemiology (439 citations) and Clinical Biochemistry (64 citations). Mark Fraser has collaborated with scholars based in United Kingdom, Netherlands and Saudi Arabia. Frequent co-authors include Andrew M. Borman, Elizabeth M. Johnson, M. Dean Palmer, Colin Campbell, Adrien Székely, Zoe Patterson, Zoe Ann Brown, Christopher J. Linton, Julian Müller and Daniel E. Larcombe. Their work appears in journals such as Medical Mycology, Journal of Fungi, Journal of Clinical Microbiology, Mycopathologia and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.